The NGS-based RNA seq market was valued at US$ 1,414.59 million in 2018 and it is projected to reach US$ 7,984.90 million in 2027; it is expected to grow at a CAGR of 19.3% from 2018 to 2027.
The NGS based RNA seq is done without a reference sequence for the strand-specific libraries that are being profiled for the rare and novel therapeutics. It is highly revolutionized study of the transcriptome which is highly sensitive and accurate for the measurement of the expression all over the transcriptome. The NGS based RNA seq provides researchers with visibility for previously undetected changes occurring in disease states, in response to therapeutics caused by different environmental conditions. In addition, this technique enables researchers to detect the known and unknown features in single assay. Moreover it assists in detecting the gene fusions, single nucleotide variants, transcript isoforms and other features without the restriction of prior data. The growth of the global NGS-based RNA seq market is attributed to the reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer. However, risks related to genetic data and high cost of NGS instruments are the major factor hindering the market growth.
The global NGS-based RNA seq market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Lucrative Regions for Global NGS-Based RNA Seq Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Reduced Cost of Genome Sequencing to Drive Global NGS-Based RNA Seq Market Growth
The growth in the adoption of the next generation sequencing is rising, recently in few years, next generation sequencing price have reduced greatly. For instance, first whole human genome sequencing cost over US$ 3billion in 2001 and it took approximately 15 years for its completion. However, the costs for the same in recent years has reduced to US$1,000 and the process requires less number of days. The cost of sequencing was approximately US$ 3 billion, which dropped down to US$ 10 million in 2006 and as the development in the technologies has increased the prices of sequencing has decreased to US$ 5,000 in 2012. Major market players such as Illumina and Hoffman La Roche Ltd have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing.
Moreover, the increase in the service provider companies in the market and their offering for next generation sequencing are cheaper. For instance, Applied Biological Materials, Inc. is an Illumina Certified Service Provider, which offer the next generation sequencing in low cost. Services such as single-end total RNA Sequencing (8 million reads, 1x75bp SE) with minimum two samples is offered in US $375. Likewise paired-end total-end sequencing (8 Million reads, 2x75bp PE) with two samples is performed in US$ 445. Whereas, miRNA seq/Small RNA sequencing (10 million, 1x75 SE) with two samples is offered in US$ 645.
Hence, considering these factors such as advances in the field of next generation sequencing, development in different methods and strategies for sequencing, notable decline in the cost of sequencing, increase in the next generation sequencing service providers are likely to propel the growth of the NGS based RNA seq.
Product & Services -Based Insights
In terms of product & services, the global NGS-based RNA seq market is segmented into sample preparation, sequencing services, sequencing platforms & consumables and data analysis, storage & management. In 2018, the sequencing platforms & consumables segment held largest share of the market. However, the data analysis, storage & management segment is estimated to register the highest CAGR during the forecast period.
Global NGS-Based RNA Seq Market, by Product & Services – 2018 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Technology -Based Insights
Based on technology, the global NGS-based RNA seq market is segmented into sequencing by synthesis (SBS), nanopore sequencing, ion semiconductor sequencing and single-molecule real-time (SMRT) sequencing. The sequencing by synthesis segment held the largest market share in 2018, also the same segment is estimated to grow at the fastest rate during the forecast period.
Application-Based Insights
In terms of application, the global NGS-based RNA seq market is segmented into diagnostics, drug discovery, precision medicine and others. In 2018, the diagnostics segment held largest share of the market. The same segment is expected to register the highest CAGR during the forecast period.
End User-Based Insights
In terms of end user, the global NGS-based RNA seq market is segmented into hospitals & clinics, academic & research institutes, pharmaceutical & biotechnology companies and other. The academic & research institutes segment held the largest share of the market in 2018, and the hospitals & clinics segment is estimated to register the highest CAGR during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
NGS-Based RNA-Sequencing Market: Strategic Insights
Market Size Value in US$ 1,414.59 Million in 2018 Market Size Value by US$ 7,984.90 Million by 2027 Growth rate CAGR of 19.3% from 2019-2027 Forecast Period 2019-2027 Base Year 2019
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
NGS-Based RNA-Sequencing Market: Strategic Insights
| Market Size Value in | US$ 1,414.59 Million in 2018 |
| Market Size Value by | US$ 7,984.90 Million by 2027 |
| Growth rate | CAGR of 19.3% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The global NGS-based RNA seq market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Global NGS-Based RNA Seq Market – by Product & Services
- Sample Preparation
- Method
- Manual Method
- Automated Method
- Workflow Step
- Library Preparation & Target Enrichment
- Fragmentation, End Repair & Size Selection
- Quality Control
- Sequencing Services
- Sequencing Platform & Consumables
- Data Analysis, Storage & Management
Global NGS-Based RNA Seq Market – by Technology
- Sequencing By Synthesis
- Nanopore Sequencing
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time (SMRT) Sequencing
Global NGS-Based RNA Seq Market – by Application
- Diagnostics
- Drug Discovery
- Precision Medicine
- Others
Global NGS-Based RNA Seq Market – by End- User
- Hospitals & Clinics
- Research Centers and Academic & Government Institutes
- Biotechnology & Pharmaceutical Companies
- Others
Global NGS-Based RNA Seq Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Pacific Biosciences of California, Inc.
- F. Hoffman-La Roche Ltd
- Agilent Technologies
- BGI
- Oxford Nanopre Technologies
- Eurofins Scientific
- Qiagen
- Perkinelmer Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product & Services , Technology , Application , End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
1. INTRODUCTION 29
1.1 SCOPE OF THE STUDY 29
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 29
2. GLOBAL NGS BASED RNA SEQ MARKET - KEY TAKEAWAYS 31
3. GLOBAL NGS BASED RNA SEQ MARKET - MARKET LANDSCAPE 34
3.1 OVERVIEW 34
3.1.1 Global NGS Based RNA Seq Market - By Product & Services 35
3.1.2 Global NGS Based RNA Seq Market - By Technology 36
3.1.3 Global NGS Based RNA Seq Market - By Application 36
3.1.4 Global NGS Based RNA Seq Market - By End User 36
3.1.5 Global NGS Based RNA Seq Market - By Geography 36
3.2 PEST ANALYSIS 37
3.2.1 North America PEST Analysis 37
3.2.2 Europe PEST Analysis 39
3.2.3 Asia Pacific PEST Analysis 41
3.2.4 Middle East & Africa PEST Analysis 43
3.2.5 South & Central America PEST Analysis 45
4. GLOBAL NGS BASED RNA SEQ MARKET - KEY MARKET DYNAMICS 47
4.1 KEY MARKET DRIVERS 47
4.1.1 Reduced Cost of Genome Sequencing 47
4.1.2 Advancements in Sequencing Technology 47
4.1.3 Next Generation Sequencing for Cancer 48
4.2 KEY MARKET RESTRAINTS 48
4.2.1 Risks Related to Genetic Data 48
4.2.2 High Cost of NGS Instruments 49
4.3 KEY MARKET OPPORTUNITIES 49
4.3.1 Application of NSG in Biomarker Discovery and Precision Medicine 49
4.3.2 Different Programs for RNA Sequencing 50
4.4 FUTURE TRENDS 50
4.4.1 Barcode Scanning for Long Reads Sequences 50
4.5 IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS 51
5. NGS BASED RNA SEQ MARKET - GLOBAL ANALYSIS 52
5.1 GLOBAL NGS BASED RNA SEQ MARKET REVENUE FORECASTS AND ANALYSIS 52
5.2 GLOBAL NGS BASED RNA SEQ MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 53
5.3 MARKET POSITIONING 54
5.4 PERFORMANCE OF KEY PLAYERS 54
5.4.1 Illumina, Inc. 54
5.4.2 Thermo Fisher Scientific Inc. 55
5.5 EXPERT OPINIONS 55
6. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY PRODUCT & SERVICES 56
6.1 OVERVIEW 56
6.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY PRODUCT & SERVICES, 2018 & 2027 (%) 56
6.3 SAMPLE PREPARATION MARKET 57
6.3.1 Overview 57
6.3.2 Global Sample Preparation Market Revenue and Forecasts to 2027 (US$ Mn) 57
6.3.3 Method Market 58
6.3.3.1 Overview 58
6.3.3.2 Manual Method Market 58
6.3.3.2.1 Overview 58
6.3.3.2.2 Global Manual Method Market Revenue and Forecasts to 2027 (US$ Mn) 59
6.3.3.3 Automated Method Market 60
6.3.3.3.1 Overview 60
6.3.3.3.2 Global Automated Method Market Revenue and Forecasts to 2027 (US$ Mn) 60
6.3.4 Workflow Step Market 61
6.3.4.1 Overview 61
6.3.4.2 Library Preparation & Target Enrichment Market 61
6.3.4.2.1 Overview 61
6.3.4.2.2 Global Library Preparation & Target Enrichment Market Revenue and Forecasts to 2027 (US$ Mn) 62
6.3.4.3 Fragmentation, End Repair & Size Selection Market 63
6.3.4.3.1 Overview 63
6.3.4.3.2 Global Fragmentation, End repair & Size Selection Market Revenue and Forecasts to 2027 (US$ Mn) 63
6.3.4.4 Quality Control Market 64
6.3.4.4.1 Overview 64
6.3.4.4.2 Global Quality Control Market Revenue and Forecasts to 2027 (US$ Mn) 64
6.4 SEQUENCING SERVICES MARKET 65
6.4.1 Overview 65
6.4.2 Global Sequencing Services Market Revenue and Forecasts to 2027 (US$ Mn) 66
6.5 SEQUENCING PLATFORM & CONSUMABLES MARKET 67
6.5.1 Overview 67
6.5.2 Global Sequencing Platform & Consumables Market Revenue and Forecasts to 2027 (US$ Mn) 68
6.6 DATA ANALYSIS, STORAGE & MANAGEMENT MARKET 69
6.6.1 Overview 69
6.6.2 Global Data Analysis, Storage & Management Market Revenue and Forecasts to 2027 (US$ Mn) 69
7. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY TECHNOLOGY 70
7.1 OVERVIEW 70
7.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY TECHNOLOGY, 2018 & 2027 (%) 70
7.3 SEQUENCING BY SYNTHESIS (SBS) MARKET 71
7.3.1 Overview 71
7.3.2 Global Sequencing By Synthesis (SBS) Market Revenue and Forecasts to 2027 (US$ Mn) 71
7.4 NANOPORE SEQUENCING MARKET 72
7.4.1 Overview 72
7.4.2 Global Nanopore Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 72
7.5 ION SEMICONDUCTOR SEQUENCING MARKET 73
7.5.1 Overview 73
7.5.2 Global Ion Semiconductor Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 73
7.6 SINGLE MOLECULE REAL TIME (SMRT) SEQUENCING MARKET 74
7.6.1 Overview 74
7.6.2 Global Single Molecule Real Time (SMRT) Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 74
8. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY APPLICATION 75
8.1 OVERVIEW 75
8.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY APPLICATION, 2018 & 2027 (%) 75
8.3 DIAGNOSTICS MARKET 76
8.3.1 Overview 76
8.3.2 Global Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn) 76
8.4 DRUG DISCOVERY MARKET 77
8.4.1 Overview 77
8.4.2 Global Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn) 77
8.5 PRECISION MEDICINE MARKET 78
8.5.1 Overview 78
8.5.2 Global Precision Medicine Market Revenue and Forecasts to 2027 (US$ Mn) 78
8.6 OTHER APPLICATIONS MARKET 79
8.6.1 Overview 79
8.6.2 Global Other Applications Market Revenue and Forecasts to 2027 (US$ Mn) 79
9. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY END USER 80
9.1 OVERVIEW 80
9.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY END USER, 2018 & 2027 (%) 80
9.3 HOSPITALS & CLINICS MARKET 81
9.3.1 Overview 81
9.3.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn) 81
9.4 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 82
9.4.1 Overview 82
9.4.2 Global Research Centers And Academic & Government Institutes Market Revenue and Forecasts to 2027 (US$ Mn) 82
9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 83
9.5.1 Overview 83
9.5.2 Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn) 83
9.6 OTHER END USERS MARKET 84
9.6.1 Overview 84
9.6.2 Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn) 84
10. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 85
10.1 OVERVIEW 85
10.2 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 86
10.3 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 86
10.3.1 North America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 87
10.3.2 North America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 87
10.4 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 88
10.5 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 88
10.6 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 89
10.7 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 89
10.8 US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 90
10.8.1 US NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 90
10.8.2 US NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 91
10.8.2.1 US Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 91
10.8.2.2 US Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 91
10.8.3 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 92
10.8.4 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 92
10.8.5 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 93
10.9 CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 94
10.9.1 Canada NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 94
10.9.2 Canada NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 95
10.9.2.1 Canada Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 95
10.9.2.2 Canada Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 95
10.9.3 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 96
10.9.4 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 96
10.9.5 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 97
10.10 MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 98
10.10.1 Mexico NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 98
10.10.2 Mexico NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 99
10.10.2.1 Mexico Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 99
10.10.2.2 Mexico Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 99
10.10.3 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 100
10.10.4 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 100
10.10.5 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 101
11. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 102
11.1 OVERVIEW 102
11.2 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 103
11.3 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 103
11.3.1 Europe Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 104
11.3.2 Europe Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 104
11.4 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 104
11.5 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 105
11.6 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 105
11.7 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 106
11.8 UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 107
11.8.1 UK NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 108
11.8.2 UK NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 108
11.8.2.1 UK Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 109
11.8.2.2 UK Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 109
11.8.3 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 109
11.8.4 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 110
11.8.5 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 110
11.9 GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 111
11.9.1 Germany NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 111
11.9.2 Germany NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 112
11.9.2.1 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 112
11.9.2.2 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 112
11.9.3 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 113
11.9.4 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 113
11.9.5 GERMANY NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 114
11.10 FRANCE NEXT GENERATION SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 115
11.10.1 France NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 115
11.10.2 France NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 116
11.10.2.1 France Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 116
11.10.2.2 France Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 116
11.10.3 France NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 117
11.10.4 France NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 117
11.10.5 FRANCE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 118
12. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 119
12.1 OVERVIEW 119
12.2 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 120
12.3 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 120
12.3.1 Asia Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 121
12.3.2 Asia Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 121
12.4 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 121
12.5 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 122
12.6 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 122
12.7 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 123
12.8 CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 124
12.8.1 China NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 125
12.8.2 China NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 125
12.8.2.1 China Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 126
12.8.2.2 China Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 126
12.8.3 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 126
12.8.4 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 127
12.8.5 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 127
12.9 INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 128
12.9.1 India NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 129
12.9.2 India NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 129
12.9.2.1 India Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 130
12.9.2.2 India Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 130
12.9.3 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 130
12.9.4 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 131
12.9.5 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 131
12.10 JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 132
12.10.1 Japan NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 132
12.10.2 Japan NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 133
12.10.2.1 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 133
12.10.2.2 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 133
12.10.3 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 134
12.10.4 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 134
12.10.5 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 135
13. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 136
13.1 OVERVIEW 136
13.2 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 137
13.3 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 137
13.3.1 Middle East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 138
13.3.2 Middle East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 138
13.4 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 139
13.5 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 139
13.6 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 140
13.7 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 140
13.8 SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 141
13.8.1 Saudi Arabia NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 141
13.8.2 Saudi Arabia NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 142
13.8.2.1 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 142
13.8.2.2 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 142
13.8.3 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 143
13.8.4 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 143
13.8.5 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 144
13.9 UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 145
13.9.1 UAE NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 145
13.9.2 UAE NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 146
13.9.2.1 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 146
13.9.2.2 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 146
13.9.3 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 147
13.9.4 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 147
13.9.5 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 148
13.10 SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 149
13.10.1 South Africa NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 149
13.10.2 South Africa NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 150
13.10.2.1 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 150
13.10.2.2 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 151
13.10.3 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 151
13.10.4 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 151
13.10.5 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 152
14. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 153
14.1 OVERVIEW 153
14.2 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 154
14.3 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 154
14.3.1 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 155
14.3.2 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 155
14.4 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 156
14.5 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 156
14.6 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 157
14.7 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 157
14.8 BRAZIL BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 158
14.8.1 Brazil NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 158
14.8.2 Brazil NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 159
14.8.2.1 Brazil Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 159
14.8.2.2 Brazil Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 159
14.8.3 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 160
14.8.4 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 160
14.8.5 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 161
15. NGS-BASED RNA-SEQ MARKET -INDUSTRY LANDSCAPE 162
15.1 OVERVIEW 162
15.2 GROWTH STRATEGIES IN THE NGS-BASED RNA-SEQ MARKET, 2016-2018 162
15.3 ORGANIC DEVELOPMENTS 162
15.3.1 Overview 162
15.4 ORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 163
15.5 PRODUCT & SERVICE LAUNCH 163
15.5.1 Recent Product & Service Launch By Players In The NGS-based RNA-seq Market 163
15.6 PRODUCT APPROVAL 164
15.6.1 Recent Product Approval By Players In The NGS-based RNA-seq Market 164
15.7 OTHERS 164
15.7.1 The NGS-based RNA-seq Market By Other Growth Strategies 164
15.8 INORGANIC DEVELOPMENTS 165
15.8.1 Overview 165
15.9 INORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 165
15.10 PARTNERSHIPS 166
15.10.1 Recent Partnerships by Players in the NGS-based RNA-seq Market 166
15.11 COLLABORATIONS 167
15.11.1 Collaborations By Players In The NGS-based RNA-seq Market 167
15.12 EXPANSION 168
15.12.1 The NGS-based RNA-seq Market By Expansion 168
15.13 ACQUISITIONS 169
15.13.1 Acquisitions By Players In The NGS-based RNA-seq Market 169
15.14 AGREEMENTS 169
15.14.1 The NGS-based RNA-seq Market By Agreements 169
16. NGS-BASED RNA-SEQ MARKET-KEY COMPANY PROFILES 170
16.1 ILLUMINA, INC. 170
16.1.1 Key Facts 170
16.1.2 Business Description 170
16.1.3 Financial Overview 171
16.1.4 Product Portfolio 171
16.1.5 Swot Analysis 172
16.1.6 Key Developments 172
16.2 THERMO FISHER SCIENTIFIC INC. 174
16.2.1 Key Facts 174
16.2.2 Business Description 174
16.2.3 Financial Overview 175
16.2.4 Product Portfolio 175
16.2.5 SWOT Analysis 176
16.2.6 Key Developments 176
16.3 PERKINELMER, INC. 177
16.3.1 Key Facts 177
16.3.2 Business Description 177
16.3.3 Financial Overview 178
16.3.4 Product Portfolio 178
16.3.5 SWOT Analysis 179
16.3.6 Key Developments 179
16.4 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 180
16.4.1 Key Facts 180
16.4.2 Business Description 180
16.4.3 Financial Information 180
16.4.4 Product Portfolio 181
16.4.5 SWOT Analysis 181
16.4.6 Key Developments 181
16.5 F. HOFFMANN-LA ROCHE LTD 182
16.5.1 Key Facts 182
16.5.2 Business Description 182
16.5.3 Financial Information 183
16.5.4 Product Portfolio 183
16.5.5 SWOT Analysis 184
16.5.6 Key Developments 184
16.6 QIAGEN 185
16.6.1 Key Facts 185
16.6.2 Business Description 185
16.6.3 Financial Information 186
16.6.4 Product Portfolio 186
16.6.5 SWOT Analysis 187
16.6.6 Key Developments 188
16.7 AGILENT TECHNOLOGIES 190
16.7.1 Key Facts 190
16.7.2 Business Description 190
16.7.3 Financial Overview 191
16.7.4 Product Portfolio 191
16.7.5 SWOT Analysis 192
16.7.6 Key Developments 192
16.8 BGI 193
16.8.1 Key Facts 193
16.8.2 Business Description 193
16.8.3 Financial Overview 193
16.8.4 Product Portfolio 193
16.8.5 SWOT Analysis 194
16.8.6 Key Developments 194
16.9 OXFORD NANOPORE TECHNOLOGIES 195
16.9.1 Key Facts 195
16.9.2 Business Description 195
16.9.3 Financial Overview 195
16.9.4 Product Portfolio 195
16.9.5 SWOT ANALYSIS 196
16.9.6 Key Developments 196
16.10 EUROFINS SCIENTIFIC 197
16.10.1 Key Facts 197
16.10.2 Business Description 197
16.10.3 Financial Overview 197
16.10.4 Product Portfolio 198
16.10.5 SWOT Analysis 198
16.10.6 Key Developments 198
17. APPENDIX 199
17.1 ABOUT THE INSIGHT PARTNERS 199
17.2 GLOSSARY OF TERMS 200
17.3 METHODOLOGY 202
17.3.1 Coverage 203
17.3.2 Secondary Research 203
17.3.3 Primary Research 204
LIST OF TABLES
TABLE 1. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 86
TABLE 2. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 87
TABLE 3. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 87
TABLE 4. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 88
TABLE 5. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 88
TABLE 6. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 89
TABLE 7. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 91
TABLE 8. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 91
TABLE 9. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 91
TABLE 10. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 92
TABLE 11. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 92
TABLE 12. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 93
TABLE 13. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 95
TABLE 14. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 95
TABLE 15. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 95
TABLE 16. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 96
TABLE 17. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 96
TABLE 18. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 97
TABLE 19. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 99
TABLE 20. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 99
TABLE 21. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 99
TABLE 22. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 100
TABLE 23. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 100
TABLE 24. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 101
TABLE 25. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 103
TABLE 26. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 104
TABLE 27. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 104
TABLE 28. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 104
TABLE 29. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 105
TABLE 30. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 105
TABLE 31. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 108
TABLE 32. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 109
TABLE 33. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 109
TABLE 34. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 109
TABLE 35. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 110
TABLE 36. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 110
TABLE 37. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 112
TABLE 38. GERMANY SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 112
TABLE 39. GERMANY SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 112
TABLE 40. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 113
TABLE 41. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 113
TABLE 42. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 114
TABLE 43. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 116
TABLE 44. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 116
TABLE 45. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 116
TABLE 46. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 117
TABLE 47. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 117
TABLE 48. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 118
TABLE 49. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 120
TABLE 50. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 121
TABLE 51. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 121
TABLE 52. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 121
TABLE 53. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 122
TABLE 54. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 122
TABLE 55. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 125
TABLE 56. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 126
TABLE 57. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 126
TABLE 58. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 126
TABLE 59. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 127
TABLE 60. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 127
TABLE 61. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 129
TABLE 62. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 130
TABLE 63. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 130
TABLE 64. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 130
TABLE 65. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 131
TABLE 66. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 131
TABLE 67. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 133
TABLE 68. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 133
TABLE 69. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 133
TABLE 70. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 134
TABLE 71. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 134
TABLE 72. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 135
TABLE 73. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 137
TABLE 74. MIDDLE EAST & AFRICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 138
TABLE 75. MIDDLE EAST & AFRICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 138
TABLE 76. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 139
TABLE 77. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 139
TABLE 78. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 140
TABLE 79. SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 142
TABLE 80. SAUDI ARABIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 142
TABLE 81. SAUDI ARABIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 142
TABLE 82. SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 143
TABLE 83. SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 143
TABLE 84. SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 144
TABLE 85. UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 146
TABLE 86. UAE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 146
TABLE 87. UAE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 146
TABLE 88. UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 147
TABLE 89. UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 147
TABLE 90. UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 148
TABLE 91. SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 150
TABLE 92. SOUTH AFRICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 150
TABLE 93. SOUTH AFRICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 151
TABLE 94. SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 151
TABLE 95. SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 151
TABLE 96. SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 152
TABLE 97. SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 154
TABLE 98. SOUTH AND CENTRAL AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 155
TABLE 99. SOUTH AND CENTRAL AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 155
TABLE 100. SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 156
TABLE 101. SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 156
TABLE 102. SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 157
TABLE 103. BRAZIL NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 159
TABLE 104. BRAZIL SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 159
TABLE 105. BRAZIL SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 159
TABLE 106. BRAZIL NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 160
TABLE 107. BRAZIL NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 160
TABLE 108. BRAZIL NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 161
TABLE 109. RECENT PRODUCT & SERVICE LAUNCH IN THE NGS-BASED RNA-SEQ MARKET 163
TABLE 110. RECENT PRODUCT APPROVAL AND ENHANCEMENTS IN THE NGS-BASED RNA-SEQ MARKET 164
TABLE 111. THE NGS-BASED RNA-SEQ MARKET BY OTHERS STRATEGIES 164
TABLE 112. RECENT PARTNERSHIPS IN THE NGS-BASED RNA-SEQ MARKET 166
TABLE 113. COLLABORATIONS IN THE NGS-BASED RNA-SEQ MARKET 167
TABLE 114. THE NGS-BASED RNA-SEQ MARKET BY EXPANSION 168
TABLE 115. ACQUISITIONS IN THE NGS-BASED RNA-SEQ MARKET 169
TABLE 116. THE NGS-BASED RNA-SEQ MARKET BY AGREEMENTS 169
TABLE 117. GLOSSARY OF TERMS, NGS BASED RNA SEQ MARKET 200
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC NGS BASED RNA SEQ MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2027 31
FIGURE 2. GLOBAL NGS BASED RNA SEQ MARKET BY PRODUCT & SERVICES, MARKET SHARE (%), 2018 32
FIGURE 3. GLOBAL NGS BASED RNA SEQ MARKET BY TECHNOLOGY, MARKET SHARE (%), 2018 32
FIGURE 4. GLOBAL NGS BASED RNA SEQ MARKET BY APPLICATION, MARKET SHARE (%), 2018 33
FIGURE 5. GLOBAL NGS BASED RNA SEQ MARKET BY END USER, MARKET SHARE (%), 2018 33
FIGURE 6. NGS BASED RNA SEQ MARKET SEGMENTATION 34
FIGURE 7. NGS BASED RNA SEQ SEGMENTATION, BY REGION 35
FIGURE 8. NORTH AMERICA : PEST ANALYSIS 37
FIGURE 9. EUROPE : PEST ANALYSIS 39
FIGURE 10. ASIA - PACIFIC : PEST ANALYSIS 41
FIGURE 11. MIDDLE EAST & AFRICA : PEST ANALYSIS 43
FIGURE 12. SOUTH & CENTRAL AMERICA : PEST ANALYSIS 45
FIGURE 13. NGS BASED RNA SEQ MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 51
FIGURE 14. GLOBAL NGS BASED RNA SEQ MARKET - REVENUE FORECASTS AND ANALYSIS - 2018- 2027 52
FIGURE 15. GLOBAL NGS BASED RNA SEQ MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2018- 2027 53
FIGURE 16. GLOBAL NGS BASED RNA SEQ MARKET - KEY MARKET PLAYERS 54
FIGURE 17. GLOBAL NGS-BASED RNA SEQ MARKET BY PRODUCT & SERVICES, 2018 & 2027 (%) 56
FIGURE 18. GLOBAL SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 57
FIGURE 19. GLOBAL MANUAL METHOD MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 59
FIGURE 20. GLOBAL AUTOMATED METHOD MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 60
FIGURE 21. GLOBAL LIBRARY PREPARATION & TARGET ENRICHMENT MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 62
FIGURE 22. GLOBAL FRAGMENTATION, END REPAIR & SIZE SELECTION MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 63
FIGURE 23. GLOBAL QUALITY CONTROL MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 64
FIGURE 24. GLOBAL SEQUENCING SERVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 66
FIGURE 25. GLOBAL SEQUENCING PLATFORM & CONSUMABLES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 68
FIGURE 26. GLOBAL DATA ANALYSIS, STORAGE & MANAGEMENT MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 69
FIGURE 27. GLOBAL NGS-BASED RNA SEQ MARKET BY TECHNOLOGY, 2018 & 2027 (%) 70
FIGURE 28. GLOBAL SEQUENCING BY SYNTHESIS (SBS) MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 71
FIGURE 29. GLOBAL NANOPORE SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 72
FIGURE 30. GLOBAL ION SEMICONDUCTOR SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 73
FIGURE 31. GLOBAL SINGLE MOLECULE REAL TIME (SMRT) SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 74
FIGURE 32. GLOBAL NGS-BASED RNA SEQ MARKET BY APPLICATION, 2018 & 2027 (%) 75
FIGURE 33. GLOBAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 76
FIGURE 34. GLOBAL DRUG DISCOVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 77
FIGURE 35. GLOBAL PRECISION MEDICINE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 78
FIGURE 36. GLOBAL OTHER APPLICATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 79
FIGURE 37. GLOBAL NGS-BASED RNA SEQ MARKET BY END USER, 2018 & 2027 (%) 80
FIGURE 38. GLOBAL HOSPITALS & CLINICS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 81
FIGURE 39. GLOBAL RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 82
FIGURE 40. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 83
FIGURE 41. GLOBAL OTHER END USERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 84
FIGURE 42. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE, BY COUNTRY, 2018 (US$ MN) 85
FIGURE 43. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 86
FIGURE 44. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 89
FIGURE 45. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 90
FIGURE 46. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 94
FIGURE 47. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 98
FIGURE 48. EUROPE NGS BASED RNA SEQ MARKET REVENUE, BY COUNTRY, 2018 (US$ MN) 102
FIGURE 49. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 103
FIGURE 50. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 106
FIGURE 51. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 108
FIGURE 52. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 111
FIGURE 53. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 115
FIGURE 54. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE, BY COUNTRY, 2018 (US$ MN) 119
FIGURE 55. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 120
FIGURE 56. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 123
FIGURE 57. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 125
FIGURE 58. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 129
FIGURE 59. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 132
FIGURE 60. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE, BY COUNTRY, 2018 (US$ MN) 136
FIGURE 61. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 137
FIGURE 62. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 140
FIGURE 63. SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 141
FIGURE 64. UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 145
FIGURE 65. SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 149
FIGURE 66. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE, BY COUNTRY, 2018 (US$ MN) 153
FIGURE 67. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 154
FIGURE 68. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 157
FIGURE 69. BRAZIL NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 158
FIGURE 70. GROWTH STRATEGIES IN THE NGS-BASED RNA-SEQ MARKET, 2016-2018 162
FIGURE 71. ORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 163
FIGURE 72. INORGANIC DEVELOPMENTS IN THE MHEALTH MARKET, 2016-2018 165
1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. Pacific Biosciences of California, Inc.
4. Qaigen
5. F. Hoffmann-La Roche AG
6. Agilent Technologies, Inc.
7. BGI
8. Oxford Nanopore Technologies
9. Perkinelmer, Inc.
10. Eurofins Scientific
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to NGS-Based RNA-Sequencing Market
Jan 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jan 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jan 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jan 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Jan 2019